Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FXNE6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,274
Award facts
- Contract value 100% obligated
- $4,273.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $4,273.96 and an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains a comprehensive IDC valued at $999,999,999.00 running through December 2026.
AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Dupixent, a specialty pharmaceutical product, reflects the company's ongoing role as a prime vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FXNE6?
SPE2DB25FXNE6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXNE6 worth?
The government has obligated $4,274 on SPE2DB25FXNE6.
Is contract SPE2DB25FXNE6 an order under another contract?
Yes. SPE2DB25FXNE6 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXNE6 competed?
The extent of competition for SPE2DB25FXNE6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award